Biotin-mediated induction of glucokinase might be of particular benefit in type 1 diabetics, in whom hepatic insulin exposure and glucokinase expression is constantly subnormal despite subcutaneous insulin therapy [217,219,220,221]. The gene discussed is INS; the disease is type 1 diabetes mellitus.